Is it Time to Squeeze Down on Sepsis? The When, What and How of Vasopressor Use in Sepsis

April 7, 2021

The purpose of this activity is to reaffirm to the pharmacy team where our current sepsis metrics come from and highlight how these recommended interventions may not benefit every septic patient. Secondly, this activity will weigh the pros and cons of fluid administration and who should be receiving the recommended fluid boluses versus who should have early vasopressor initiation instead. We will also discuss the role of midodrine and whether this helps facilitate vasopressor discontinuation.

Target Audience

  • Pharmacists

Learning Objectives

  1. List the key elements of the sepsis metrics recommended for the management of septic shock
  2. Describe the patient population who would benefit most from early vasopressor use
  3. Evaluate a patient case and choose an appropriate vasopressor
  4. Define the role of midodrine for the discontinuation of parenteral vasoactive medications
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
Course opens: 
04/07/2021
Course expires: 
05/23/2021
Event starts: 
04/07/2021 - 7:00am
Event ends: 
04/07/2021 - 8:00am
Cost:
$0.00
University of Rochester Medical Center
Rochester, NY
United States
The presenter will discuss off-label use of drugs
 
Relevant financial relationships: Christine Groth (planning committee member) received consultant/advisory board fees from Johnson & Johnson and PAR Sterile Pharmaceuticals  
 
Planning committee members
 
Linda Thomas, PharmD, BCPS
Pharmacy Residency Coordinator
University of Rochester Medical Center
 
Christine Growth, PharmD, FCCM, BCCCP
Clinical Pharmacy Coordinator, PGY-2 Critical Care Residency Program Director
University of Rochester Medical Center
 
Course reviewer
 
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient, Inc.
 
Presenter
 
Mikaela R. Brown, PharmD
PGY-2 Critical Care Pharmacy Resident
University of Rochester Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statement:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-21-113-L01-P

Available Credit

  • 1.00 ACPE Pharmacist

Price

Cost:
$0.00
Please login or register to take this course.